Literature DB >> 15126005

Glibenclamide-induced acute haemolytic anaemia revealing a G6PD-deficiency.

Stéphane Vinzio1, Emmanuel Andrès, Anne-Elisabeth Perrin, Jean-Louis Schlienger, Bernard Goichot.   

Abstract

A 58-year-old woman was admitted at diagnosis of type 2 diabetes without keto-acidosis. Blood glucose was normalized initially with insulin. Whilst taking glibenclamide, she developed acute haemolysis. She was homozygous for glucose-6-phosphate dehydrogenase (G6PD) deficiency and had no other factors predisposing haemolysis. We reviewed the literature and discuss the relationship between glibenclamide and haemolytic crisis and between G6PD-deficiency and diabetes.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15126005     DOI： 10.1016/j.diabres.2003.11.006

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN： 0168-8227            Impact factor:   5.602


  9 in total

1.  High frequency of diabetes and impaired fasting glucose in patients with glucose-6-phosphate dehydrogenase deficiency in the Western brazilian Amazon.

Authors:  Marli S Santana; Wuelton M Monteiro; Mônica R F Costa; Vanderson S Sampaio; Marcelo A M Brito; Marcus V G Lacerda; Maria G C Alecrim
Journal:  Am J Trop Med Hyg       Date:  2014-05-27       Impact factor: 2.345

2.  PharmGKB summary: very important pharmacogene information for G6PD.

Authors:  Ellen M McDonagh; Caroline F Thorn; José M Bautista; Ilan Youngster; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2012-03       Impact factor: 2.089

3.  Glucose 6 phosphate dehydrogenase deficiency unmasked by diabetic ketoacidosis: an underrated phenomenon.

Authors:  Ayushi Agarwal; Deepak Nayak M; Asha Patil; Chethan Manohar
Journal:  J Clin Diagn Res       Date:  2013-12-15

Review 4.  Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based review.

Authors:  Ilan Youngster; Lidia Arcavi; Renata Schechmaster; Yulia Akayzen; Hen Popliski; Janna Shimonov; Svetlana Beig; Matitiahu Berkovitch
Journal:  Drug Saf       Date:  2010-09-01       Impact factor: 5.228

Review 5.  G6PD Variants and Haemolytic Sensitivity to Primaquine and Other Drugs.

Authors:  Germana Bancone; Cindy S Chu
Journal:  Front Pharmacol       Date:  2021-03-15       Impact factor: 5.810

6.  Glucose-6-Phosphate dehydrogenase deficiency associated hemolysis in a cohort of new onset type 1 diabetes children in Guangdong province, China.

Authors:  Aijing Xu; Minyan Jiang; Wen Zhang; Yunting Lin; Yongxian Shao; Huifen Mei; Jing Cheng; Cuili Liang; Cuiling Li; Xiuzhen Li; Li Liu
Journal:  Diabetol Metab Syndr       Date:  2022-03-21       Impact factor: 3.320

7.  Manifestation of glucose-6-phosphate dehydrogenase deficiency in the wake of new-onset type 1 diabetes mellitus: a case report.

Authors:  Sandhya Govindarajan; Imran Zamir; Sunil Bagewadi; Emily Moore
Journal:  J Med Case Rep       Date:  2022-08-26

8.  New onset diabetes complicated by haemolysis and rhabdomyolysis: a case report and review of the literature.

Authors:  Clare M Galtrey; Rohan Pathansali
Journal:  J Med Case Rep       Date:  2008-05-16

9.  Effect of combined G6PD deficiency and diabetes on protein oxidation and lipid peroxidation.

Authors:  Naif S Karadsheh; Nisreen A Quttaineh; Salem N Karadsheh; Mohammad El-Khateeb
Journal:  BMC Endocr Disord       Date:  2021-12-23       Impact factor: 2.763
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.